1,727 filings
Page 5 of 87
6-K
AZN
Astrazeneca plc
11 Sep 23
Fasenra Phase III Egpa Trial Met Primary Endpoint
11:07am
6-K
AZN
Astrazeneca plc
6 Sep 23
Update on Us Review of Ultomiris for Nmosd
6:59am
6-K
AZN
Astrazeneca plc
1 Sep 23
Total Voting Rights
10:20am
25-NSE
The Nasdaq Stock Market LLC
16 Aug 23
Exchange delisting
4:09pm
6-K
AZN
Astrazeneca plc
1 Aug 23
Total Voting Rights
12:23pm
6-K
AZN
Astrazeneca plc
28 Jul 23
Current report (foreign)
8:46am
6-K
AZN
Astrazeneca plc
28 Jul 23
Alexion Enters Gene Therapy Agreement with Pfizer
6:25am
6-K
AZN
Astrazeneca plc
17 Jul 23
Beyfortus Approved In Us for Infant RSV Prevention
2:08pm
6-K
AZN
Astrazeneca plc
3 Jul 23
Total Voting Rights
1:35pm
6-K
AZN
Astrazeneca plc
3 Jul 23
Dato-dxd Significantly Improved PFS In Lung Cancer
8:30am
11-K
AZN
Astrazeneca plc
28 Jun 23
Annual report of employee stock purchases
5:28pm
6-K
AZN
Astrazeneca plc
9 Jun 23
Nirsevimab Recommended for Infant RSV Protection
6:38am
6-K
AZN
Astrazeneca plc
9 Jun 23
Astrazeneca Agreement with Quell Therapeutics
6:21am
6-K
AZN
Astrazeneca plc
2 Jun 23
Imfinzi Improved PCR In Gastric and Gej Cancers
12:12pm
6-K
AZN
Astrazeneca plc
1 Jun 23
Block Listing Interim Review
12:07pm
6-K
AZN
Astrazeneca plc
1 Jun 23
Total Voting Rights
12:00pm
6-K
AZN
Astrazeneca plc
1 Jun 23
Lynparza Approved In Us for Brcam Prostate Cancer
6:36am
6-K
AZN
Astrazeneca plc
26 May 23
Imfinzi + Lynparza Prolonged PFS In Endometrial Cancer
6:18am
25-NSE
The Nasdaq Stock Market LLC
25 May 23
Exchange delisting
4:39pm
6-K
AZN
Astrazeneca plc
22 May 23
Directorate Change
6:53am